跳至主要内容
临床试验/IRCT2016101710324N34
IRCT2016101710324N34已完成2 期

The effect of metoclopramide administration to mother on newborn’s bilirubin and mother’s prolactine: a randomized controlled clinical trial

Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 112 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 49 years(—)
性别
Female

入选标准

  • Healthy full-term pregnancy; Mothers with singleton pregnancy; Being Lactating, and having tendency and motivation to breast-feeding; Living in Tabriz; Willingness to continue in the study; -Having at least literacy of reading and writing.
  • Exclusion criteria: Newborns with birth defects; Newborns that need to neonatal intensive cares; Neonatal jaundice in first day after birth; Neonatal metabolic disease; Taking of hormonal drugs by mothers such as estrogen; Taking of medications that affect the serum prolactin like halopridol, reserpine, mytel- dopa, opiates and cimetidine; Maternal depression; History of previous depression; Inverted nipple; Having absolute or relative contraindication for breast-feeding in the mother including diseases such as untreated TB, infection with HIV, CMV, herpes simplex virus and hepatitis and taking of radioactive drugs and illegal drugs during the breastfeeding period, such as methotrexate, lithium, cyclophosphamide, hydroxyurea, phencyclidine, phenidone, opiate substances and metronidazole; History of chronic disease in the mother

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences

相似试验

The effect of metoclopramide administration to... | 临床试验